MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gait analysis using Wearable Sensors: different gait metrics can differentiate Parkinson’s Disease Patients from Healthy Controls and Parkinson’s Disease patients in different medication status

R. Barbosa, M. Medonça, R. Oliveira, M. Santos, A. Abreu, P. Bastos, P. Pita-Lobo, A. Valadas, L. Correia-Guedes, J. Ferreira, M. Rosa, R. Matias, M. Coelho (Lisbon, Portugal)

Meeting: 2022 International Congress

Abstract Number: 350

Keywords: Levodopa(L-dopa), Parkinson’s, Wearing-off fluctuations

Category: Technology

Objective: To identify which gait metrics better distinguish PD-OFF from PD Best-ON and PD from HC, using a dimensionality-reduction method

Background: Objective gait analysis using wearable sensors allows a better characterization of Parkinson’s Disease (PD) gait, with potential usefulness as a diagnostic and prognostic biomarker. The set of kinematic variables that better characterize PD gait and better differentiate PD from healthy controls (HC) has not been established yet.

Method: 17 PD (OFF and Best-ON) and 34 HC matched for age and sex were evaluated. For gait assessment, patients walked 3x along a 4-meter-long corridor at a self-selected speed wearing a full-body set of 15 inertial measurement units (IMUs). Kinematic data was collected to reconstruct each subject’s body motion using a 3D kinematic model of the skeletal system. Principal Component Analysis (PCA) was performed to reduce the number of kinematic variables, and the resulting Principal Components (PC) were used to train a tree-based classifier (DP OFF vs DP Best-On, DP OFF vs HC and DP Best-ON vs HC).

Results: Mean age and mean disease duration were 60.2±8.1 and 12.1±5.1 years, respectively. MDS-UPDRS III score was 50.4±11.3(OFF) and 21.8±8.9 (Best-ON). PD OFF and Best-ON were discriminated mainly by spaciotemporal and angular variables with 80% precision (80% sensibility and specificity). Spaciotemporal and nonlinear metrics differentiated PD-OFF from HC with 90% precision (100% sensibility and 80% specificity). Discrimination between PD Best-On and HC was possible with a 90% precision (100% sensibility and 80% specificity) using non-linear and asymmetry related metrics.

Conclusion: The capacity of levodopa to modulate spaciotemporal and angular metrics probably explains the ability of these metrics to distinguish between OFF and Best-On states. In the OFF state, fundamental differences between PD and HC fall on spatiotemporal metrics, whereas these metrics are not able to differentiate PD in the Best-On state from HC. Instead, this distinction is possible using metrics related to the dynamic stability of gait and asymmetry.

To cite this abstract in AMA style:

R. Barbosa, M. Medonça, R. Oliveira, M. Santos, A. Abreu, P. Bastos, P. Pita-Lobo, A. Valadas, L. Correia-Guedes, J. Ferreira, M. Rosa, R. Matias, M. Coelho. Gait analysis using Wearable Sensors: different gait metrics can differentiate Parkinson’s Disease Patients from Healthy Controls and Parkinson’s Disease patients in different medication status [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/gait-analysis-using-wearable-sensors-different-gait-metrics-can-differentiate-parkinsons-disease-patients-from-healthy-controls-and-parkinsons-disease-patients-in-different-medicati/. Accessed May 19, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gait-analysis-using-wearable-sensors-different-gait-metrics-can-differentiate-parkinsons-disease-patients-from-healthy-controls-and-parkinsons-disease-patients-in-different-medicati/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley